3.85
price down icon3.51%   -0.14
 
loading

Mannkind Corp Aktie (MNKD) Neueste Nachrichten

pulisher
Jun 17, 2025

MannKind stock hits 52-week low at $3.70 - Investing.com

Jun 17, 2025
pulisher
Jun 11, 2025

Top 3 Health Care Stocks That May Rocket Higher This Quarter - Benzinga

Jun 11, 2025
pulisher
Jun 10, 2025

Insider Sell: Steven Binder Sells 64,085 Shares of MannKind Corp (MNKD) - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

MannKind director Steven Binder sells $256,340 in shares By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

MannKind director Steven Binder sells $256,340 in shares - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

Phase II home run: Insmed’s TPIP hits hypertension endpoints - BioWorld MedTech

Jun 10, 2025
pulisher
Jun 10, 2025

MannKind stock touches 52-week low at $4.04 amid market shifts - Investing.com

Jun 10, 2025
pulisher
Jun 09, 2025

MannKind to present inhaled insulin study at ADA event By Investing.com - Investing.com Canada

Jun 09, 2025
pulisher
Jun 09, 2025

MannKind to present inhaled insulin study at ADA event - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Breakthrough in Pediatric Diabetes Care: MannKind Phase 3 Trial Data Reveals New Inhaled Insulin Treatment Option - Stock Titan

Jun 09, 2025
pulisher
Jun 09, 2025

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23 - Yahoo Finance

Jun 09, 2025
pulisher
Jun 05, 2025

MannKind at Jefferies Global Healthcare: Strategic Growth and Innovation By Investing.com - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

MannKind at Jefferies Global Healthcare: Strategic Growth and Innovation - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

MannKind To Present At Jefferies Global Healthcare Conference; Webcast At 2:35 PM ET - Nasdaq

Jun 05, 2025
pulisher
May 28, 2025

Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit - Seeking Alpha

May 28, 2025
pulisher
May 27, 2025

Type 1 Diabetes Didn't Stop This INDYCAR Driver: Conor Daly Inspires Detroit Youth Before Grand Prix - Stock Titan

May 27, 2025
pulisher
May 27, 2025

MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition - Seeking Alpha

May 27, 2025
pulisher
May 20, 2025

MannKind stock touches 52-week low at $4.34 amid market shifts - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

MannKind at RBC Conference: Strategic Growth and Innovation By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

MannKind at RBC Conference: Strategic Growth and Innovation - Investing.com

May 20, 2025
pulisher
May 20, 2025

MannKind To Present At RBC Capital Markets Conference; Webcast At 8:00 AM ET - Nasdaq

May 20, 2025
pulisher
May 16, 2025

Most adults with type 1 diabetes using inhaled insulin increase daily dose over 30 weeks - Healio

May 16, 2025
pulisher
May 15, 2025

MannKind corp director Steven Binder sells $375,875 in stock By Investing.com - Investing.com Nigeria

May 15, 2025
pulisher
May 15, 2025

MannKind EVP David Thomson sells shares worth $150,597 By Investing.com - Investing.com India

May 15, 2025
pulisher
May 15, 2025

MannKind EVP David Thomson sells shares worth $150,597 - Investing.com

May 15, 2025
pulisher
May 15, 2025

MannKind corp director Steven Binder sells $375,875 in stock - Investing.com

May 15, 2025
pulisher
May 15, 2025

MannKind CMO steps down, transition plan set - Investing.com

May 15, 2025
pulisher
May 13, 2025

MannKind to Present at Upcoming Investor Conferences - The Globe and Mail

May 13, 2025
pulisher
May 11, 2025

MannKind Corporation (NASDAQ:MNKD) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025
pulisher
May 09, 2025

MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Decoding MannKind Corp (MNKD): A Strategic SWOT Insight - GuruFocus

May 09, 2025
pulisher
May 08, 2025

10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey

May 08, 2025
pulisher
May 08, 2025

MannKind: Q1 Earnings Snapshot - MySA

May 08, 2025
pulisher
May 08, 2025

Earnings call transcript: MannKind Q1 2025 revenue beats, stock dips - Investing.com

May 08, 2025
pulisher
May 08, 2025

MannKind (MNKD) Surpasses Q1 Revenue Expectations with Strong Gr - GuruFocus

May 08, 2025
pulisher
May 08, 2025

MannKind (MNKD) Surpasses Q1 Revenue Expectations with Strong Growth | MNKD Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

MannKind Corp Q1 2025 Earnings: EPS Meets Estimates at $0.04, Revenue Surpasses Expectations at $78 Million - GuruFocus

May 08, 2025
pulisher
May 08, 2025

MannKind Corporation Reports First Quarter 2025 Financial Results - TradingView

May 08, 2025
pulisher
May 08, 2025

MANNKIND CORP SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

MannKind Corp (MNKD) Q1 2025 Earnings Report Preview: What To Ex - GuruFocus

May 07, 2025
pulisher
May 07, 2025

MannKind Corp (MNKD) Q1 2025 Earnings Report Preview: What To Expect - Yahoo Finance

May 07, 2025
pulisher
May 01, 2025

MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025 - The Globe and Mail

May 01, 2025
pulisher
Apr 29, 2025

The Potential Rise in the Price of Mannkind Corp (MNKD) following insiders activity - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

Solidion Technology Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 29, 2025
pulisher
Apr 23, 2025

MNKD (Mannkind Corp) may reap gains as insiders became active recently - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Mannkind Corp (MNKD) is looking forward to a strong quarter - Sete News

Apr 23, 2025
$20.52
price down icon 1.13%
$35.85
price down icon 0.82%
$21.20
price up icon 1.12%
$104.73
price down icon 0.91%
$102.67
price down icon 2.16%
biotechnology ONC
$266.48
price down icon 0.21%
Kapitalisierung:     |  Volumen (24h):